Literature DB >> 3455633

Total bone calcium in normal women: effect of age and menopause status.

J C Gallagher1, D Goldgar, A Moy.   

Abstract

Bone density in different regions of the skeleton was measured in 392 normal women aged 20-80 years by dual photon absorpiometry. In premenopausal women, aged 25-50 years, multiple regression analysis of regional bone density on age, height, and weight showed a small significant decrease in total bone density (less than 0.01) but no significant change in other regions of the skeleton. In postmenopausal women there were highly significant decreases in all regions of the skeleton (p less than 0.001), and bone density in these areas decreased as a logarithmic function of years since menopause. Based on multiple regression analyses, the decrease in spine density and total bone calcium was 2.5-3.0 times greater in the 25 years after menopause than the 25 years before menopause. The largest change, however, occurred in the first five years after menopause. During this time the estimated annual change in spine density and total bone calcium was about 10 times greater than that in the premenopausal period. These results demonstrate the important effect of the menopause in determining bone mass in later life.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3455633     DOI: 10.1002/jbmr.5650020605

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  36 in total

1.  Marrow adipogenesis and bone loss that parallels estrogen deficiency is slowed by low-intensity mechanical signals.

Authors:  D Krishnamoorthy; D M Frechette; B J Adler; D E Green; M E Chan; C T Rubin
Journal:  Osteoporos Int       Date:  2015-09-01       Impact factor: 4.507

2.  Risk for osteoporosis in black women.

Authors:  J F Aloia; A Vaswani; J K Yeh; E Flaster
Journal:  Calcif Tissue Int       Date:  1996-12       Impact factor: 4.333

3.  The effect of bilateral oophorectomy on bone mineral density.

Authors:  Alper Hayirlioglu; Hüsnü Gökaslan; Nurten Andaç
Journal:  Rheumatol Int       Date:  2006-05-20       Impact factor: 2.631

4.  Single and multiple ascending dose studies of a novel tissue-selective oestrogen receptor modulator, CHF 4227, in healthy postmenopausal women.

Authors:  Maurizio Civelli; Alessandro Piero Monici Preti; Valentina Cenacchi; Ivano Rondelli; Daniele Guastalla; Antoine Tarral; Philippe Dostert; Yann Guillevic; Marie-Claude Homery
Journal:  Br J Clin Pharmacol       Date:  2007-03-16       Impact factor: 4.335

Review 5.  Role of oestrogen in the development of osteoporosis.

Authors:  T C Hillard; J C Stevenson
Journal:  Calcif Tissue Int       Date:  1991       Impact factor: 4.333

6.  Bone diminution of osteoporotic females at different skeletal sites.

Authors:  C Mautalen; E Vega; G Ghiringhelli; G Fromm
Journal:  Calcif Tissue Int       Date:  1990-04       Impact factor: 4.333

7.  Determinants of bone density in normal women: risk factors for future osteoporosis?

Authors:  J C Stevenson; B Lees; M Devenport; M P Cust; K F Ganger
Journal:  BMJ       Date:  1989-04-08

8.  Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.

Authors:  R Civitelli; S Gonnelli; F Zacchei; S Bigazzi; A Vattimo; L V Avioli; C Gennari
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

9.  Quantitative ultrasound of the calcaneus in a Korean population: reference data and relationship to bone mineral density determined by peripheral dual X-ray absorptiometry.

Authors:  Min-Ho Shin; Sun-Seog Kweon; Kyeong-Soo Park; Heon Heo; Seung-joon Kim; Hae-Sung Nam; Seul-Ki Jeong; Eun-Kyung Chung; Jin-Su Choi
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

Review 10.  Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use.

Authors:  S Patel; A R Lyons; D J Hosking
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.